Authors: Baldé Elhadj yaya, Barry Ibrahima Sory, Camara Ousmane Mamadama, Bah Abdoulaye, Keita Fatoumata Binta, Touré Abdoulaye Fodé, Tounkara Ibrahima Kalil, Kaba Abdoul Karim, Diallo Souleymane M’Bara, Koné Alpha, Béavogui Mariame, Baldé Mamadou Dadhi.
Coronavirus disease 2019 (COVID-19), is a global pandemic that has affected 600 million cases worldwide [1] and more than 3.3 million cases in Japan in February 2022 [2]. Its impact in patients with comorbidities with cardiovascular risk factors such as high blood pressure (HBP) is unpredictable. We aimed through this study to evaluate the psychological impact of COVID-19 in hypertensive patients hospitalized at the Gbessia epidemiological treatment center. We conducted a retrospective descriptive study from November 1, 2020 to April 30, 2021 covering all known or incidentally discovered hypertensive patients hospitalized at the Gbessia epidemiological treatment center for COVID-19. Hypertensive patients represented 16.11% with an average age of 58.25#23 years with a female predominance at 51%, 36.19% of patients did not present symptoms and in symptomatic forms the picture was dominated by asthenia (27.10%), dyspnea (20.95%), and fever (15.71%). The majority of patients (49.05%) were in Grade 1 of High Blood Pressure (WHO). The study showed that the psychological impact was marked by an anxiety-depressive state in the majority of cases (62%). This psychological state showed a favorable evolution in the vast majority of our patients (81%). It should be noted through this study that the level of anxiety and depression linked to COVID-19 infection in hypertensive patients is not negligible and this must be a considerable element in the management of these patients.
View/Download pdf